- ?? Blog ActionCovid1984.org
- ?? Irish Examiner
- Inverse
- ?? Gript media
- Blake-Lemoine - LaMBDA
- ?? Over Dee Wall
- The Defender News
- ?? BreakingNews.ie
- Dr Vernon Coleman
- Rebel News
- Vaccine Choice Canada NEWS
- SHFT Plan
- The Expose
- ?? Robert Pierzyński PJ
- James Roguskii - Substack
- ?? The Burkean
- Liberty Tactics IM
- stewpeters.com
- Technocracy News
- Interesting Engineering
- ?? Media Hub Ireland
- ?? The Irish Inquiry
- ?? Andy Heasman
- ?? GriptMedia
- ?? WeThePeople.ie
- ?? Action-Covid-1984
- ?? Lets wake up our Capital
- ?? Lets Wake Up Call!!!
- WW Freedom Rallies
- Piers Corbyn
- ?? Tracey OMahony
- ?? The Irish Git
- eIRe is falling
- Peter Madden Channel
- rish Farmers,Food & Family
- Gemma O'Doherty
What's new
What's new
Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Date of authorisation: 17/03/2011, Revision: 38, Status: Authorised
Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Date of authorisation: 17/03/2011, Revision: 38, Status: Authorised
19 December 2024
Veterinary medicines European public assessment report (EPAR): Nobivac L4, Vaccine to prevent Leptospira infections in dogs, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Nobivac L4, Vaccine to prevent Leptospira infections in dogs, Status: Authorised
19 December 2024
Veterinary medicines European public assessment report (EPAR): Versican Plus DHPPi, canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Versican Plus DHPPi, canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus, Status: Authorised
19 December 2024
Veterinary medicines European public assessment report (EPAR): Versican Plus DHPPi/L4, live, attenuated Canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus inactivated, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Versican Plus DHPPi/L4, live, attenuated Canine distemper virus, canine adenovirus, canine parvovirus, canine parainfluenza virus inactivated, Status: Authorised
19 December 2024
Trametinib product-specific bioequivalence guideline
Trametinib product-specific bioequivalence guideline
19 December 2024
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised
19 December 2024
Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
19 December 2024
Human medicines European public assessment report (EPAR): Carbaglu, carglumic acid, Date of authorisation: 24/01/2003, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Carbaglu, carglumic acid, Date of authorisation: 24/01/2003, Revision: 20, Status: Authorised
19 December 2024
Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 11, Status: Authorised
19 December 2024